Home
Categories
EXPLORE
True Crime
Comedy
Sports
Society & Culture
Business
News
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/80/85/fb/8085fb34-42a3-e8aa-7432-b8619622e689/mza_4447364064558007123.jpg/600x600bb.jpg
The Bridge Project Podcast
SS 105
8 episodes
3 days ago
This is a platform that connects the citizen with the state and academia. We try to create a dialogue on the technicalities of law, politics and economics in understandable terms. Follow us on LinkedIn for interesting insights & updates.
Show more...
Business News
News
RSS
All content for The Bridge Project Podcast is the property of SS 105 and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This is a platform that connects the citizen with the state and academia. We try to create a dialogue on the technicalities of law, politics and economics in understandable terms. Follow us on LinkedIn for interesting insights & updates.
Show more...
Business News
News
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/1792831/1792831-1577767515104-0c224fba732d2.jpg
EXPLAINER: Cyrus Mistry Termination Case
The Bridge Project Podcast
16 minutes 22 seconds
5 years ago
EXPLAINER: Cyrus Mistry Termination Case
I have discussed four major issues of the widely noticed NCLAT judgment: 1. What is the scope of Section 241 and 242 of the Companies Act, 2013 for relief against oppression and mismanagement 2. Whether the tribunal can hold any Article illegal on the ground that it is illegal 3. Whether the termination of mr Cyrus Mistry was illegal 4. Whether the conversion of the public company Tata Sons Ltd. into a priavte company was legal.
The Bridge Project Podcast
This is a platform that connects the citizen with the state and academia. We try to create a dialogue on the technicalities of law, politics and economics in understandable terms. Follow us on LinkedIn for interesting insights & updates.